The Real Economics of Value Based Care

• Erik Johnson Senior Vice President and National Practice Lead, Value Based Care, Optum
• Lyle Berkowitz, MD Founder and Chairman, KeyCare and Editor-in-Chief, THMT

Is value based care truly aligning incentives — or redistributing financial risk across payers, providers, and patients in ways that compress margins and shift burden? Is telehealth a costsaving lever under properly structured risk contracts — or perceived as a margin threat?

At a time when value based care dominates policy rhetoric, this episode moves past theory and into financial reality. This discussion directly examines whether value based care is delivering on its economic promise — or simply reshuffling financial risk across the system.

This episode also addresses the deeper economic tension beneath the surface: Who wins, who loses, and who is subsidizing whom?

Many organizations talk about the power of data but too few really understand the full potential. Utilizing a strategic framework that redefines the roles of collaboration and innovation, see how one organization built competitive differentiators by expanding upon the concept of a data analytics platform to create a data operating system and beyond enterprise analytics to facilitating an ecosystem.

The 30% Problem: Solving Pharmaceutical Waste with Blockchain

With up to 30% of donated pharmaceutical aid products being diverted, stolen or going to waste in this session we will learn how blockchain technology is addressing some of the biggest trust challenges in the global supply chain. Supply chain issues may prevent people that are in greatest need of life-saving medicines from being treated. Through the use of a Decentralized Knowledge Graph and blockchain technology firms and governmental aid organizations now have visibility to supply chain traceability and transparency of donated medicines. The session will additionally cover ancillary benefits with the implementation of such a solution.